In “Chinese Listed Companies Quality Development Forum 2020” hosted by China Securities Network and People’s Government of Haikou City, winners of “Golden Bull Award: Most Valuable Investment” were announced. The “Golden Bull Award: Most Valuable Investment” is based on the statistical sample of 3,039 A-share listed companies in China, and 17 key indicators are analyzed by principal component analysis in five aspects: profitability, solvency, asset management capacity, growth capacity, and innovation capacity. In 100 Winners of this award, 31 of them are healthcare companies as Yiling Pharmaceutical, Sinopharm, Yunnan Baiyao Group, Pien Tze Huang, and others. (Source: eastmoney)

Comments are closed.